Delivery Order SPE2DB24D3014-SPE2DB25FKTFR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 17, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by July 18, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,383.93 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 1, 2025, with completion expected by August 4, 2025. This firm fixed-price contract, issued without set-aside designation, leverages AmerisourceBergen's established relationship with DLA through competitive procurement procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $3,298.53 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,245.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025. This firm fixed price delivery order, with an ultimate completion date of July 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a $1,179.55 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with a completion date of August 20, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a delivery order valued at $12,612.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitive, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $12,012 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.999 billion vehicle extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKTFRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,633.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with completion scheduled for April 25, 2025. This delivery order exemplifies the Defense Logistics Agency's pharmaceutical supply chain operations in support of military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard. Trulicity is a diabetes medication commonly utilized within military medical treatment facilities. The contract reflects the established relationship between DLA and AmerisourceBergen through the broader Pharmaceutical Prime Vendor Global Program, which enables flexible procurement of essential pharmaceutical products to support military personnel healthcare needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 4/24/25 |